Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Leukemia Research
|
November 17, 2012
Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment
Wenqing Qi, Catherine Spier, Xiaobing Liu, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
May 28, 2026
TSG-6 Exacerbates Myocardial Ischemia-Reperfusion Injury by Activating NLRP3 Inflammasome and Regulating Macrophage Polarization
Run Cao, Ruomei Li, Weicheng Bu, et al.
Biochemical Pharmacology
|
February 5, 2011
Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma
Wenqing Qi, Laurence S Cooke, Xiaobing Liu, et al.
Journal of Inflammation Research
|
February 11, 2025
Metformin Ameliorates Ulcerative Colitis Through Inhibiting NLRP3 Inflammasome Activation
Run Cao, Jing Jing, Yuting Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 2012
Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma
Daruka Mahadevan, Amy Stejskal, Laurence S Cooke, et al.
Oncotarget
|
January 6, 2015
Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST)
Daruka Mahadevan, Noah Theiss, Carla Morales, et al.
Plos One
|
June 4, 2014
Alisertib added to rituximab and vincristine is synthetic lethal and potentially curative in mice with aggressive DLBCL co-overexpressing MYC and BCL2
Daruka Mahadevan, Carla Morales, Laurence S Cooke, et al.
Cancer Investigation
|
November 17, 2011
An analog of withaferin A activates the MAPK and glutathione "stress" pathways and inhibits pancreatic cancer cell proliferation
Xiaobing Liu, Wenqing Qi, Laurence S Cooke, et al.
Scientific Reports
|
August 19, 2025
Correction: Shikonin inhibits NLRP3 inflammasome activation and controls inflammatory disease
Jing Huang, Mengmeng Dai, Xinyu Huang, et al.
Scientific Reports
|
May 30, 2025
Shikonin inhibits NLRP3 inflammasome activation and controls inflammatory disease
Jing Huang, Mengmeng Dai, Xinyu Huang, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Leukemia Research
|
November 17, 2012
Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment
Wenqing Qi, Catherine Spier, Xiaobing Liu, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
May 28, 2026
TSG-6 Exacerbates Myocardial Ischemia-Reperfusion Injury by Activating NLRP3 Inflammasome and Regulating Macrophage Polarization
Run Cao, Ruomei Li, Weicheng Bu, et al.
Biochemical Pharmacology
|
February 5, 2011
Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma
Wenqing Qi, Laurence S Cooke, Xiaobing Liu, et al.
Journal of Inflammation Research
|
February 11, 2025
Metformin Ameliorates Ulcerative Colitis Through Inhibiting NLRP3 Inflammasome Activation
Run Cao, Jing Jing, Yuting Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 2012
Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma
Daruka Mahadevan, Amy Stejskal, Laurence S Cooke, et al.
Oncotarget
|
January 6, 2015
Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST)
Daruka Mahadevan, Noah Theiss, Carla Morales, et al.
Plos One
|
June 4, 2014
Alisertib added to rituximab and vincristine is synthetic lethal and potentially curative in mice with aggressive DLBCL co-overexpressing MYC and BCL2
Daruka Mahadevan, Carla Morales, Laurence S Cooke, et al.
Cancer Investigation
|
November 17, 2011
An analog of withaferin A activates the MAPK and glutathione "stress" pathways and inhibits pancreatic cancer cell proliferation
Xiaobing Liu, Wenqing Qi, Laurence S Cooke, et al.
Scientific Reports
|
August 19, 2025
Correction: Shikonin inhibits NLRP3 inflammasome activation and controls inflammatory disease
Jing Huang, Mengmeng Dai, Xinyu Huang, et al.
Scientific Reports
|
May 30, 2025
Shikonin inhibits NLRP3 inflammasome activation and controls inflammatory disease
Jing Huang, Mengmeng Dai, Xinyu Huang, et al.
Page
of 4